Posts

Posted on

Panaxia Israel announces estimated record revenues of at least 19 million in Q1 2021

The revenues reflect growth of over 56% compared to the corresponding period the previous year and over 12% compared to Q4 2020 – consistent growth over 14 straight quarters

The revenues include income from exports of Panaxia products to Germany, which began at the end of Q4 2020; towards the end of Q1 2021, the company began commercial exports of its products to Cyprus

PR Newswire

LOD, Israel, April 12, 2021 /PRNewswire/ — The Israeli subsidiary of Panaxia Global, Panaxia Labs Israel Ltd. (“Panaxia Israel”) (TASE: PNAX), Israel’s largest manufacturer of medical cannabis products, today announced its estimated revenues for the first quarter of 2021. According to Panaxia’s estimates, its consolidated (unaudited) revenues for the first quarter of 2021 are expected to reach no less than 19 million.

Estimated total revenues in the first quarter of 2021, which reflect a continuation of the growth trend in Panaxia’s operations and constitute growth of over 56% compared to revenues in the corresponding quarter the previous year, which amounted to approximately 12.2 million.

Compared to revenues in the fourth quarter of 2020, which amounted to approximately 17 million, the estimated revenues reflect double-digit growth in excess of 12% in the first quarter.


Dadi Segal, CEO of Panaxia Israel, said, “We are proud to close out the first quarter of 2021 with record revenues and double-digit growth compared to the previous and corresponding quarter the previous year. This quarter’s results are the initial results of the implementation of Panaxia’s export strategy, with the commencement of sales of our premium products in Germany and Cyprus. These two markets are strictly regulated and require that medical cannabis products be dispensed to patients according to a prescription for a specific brand. We are focused on deepening penetration of these markets and others in Europe in the coming quarters, as well as our focus on the production of products for the premium sector in the local market.”

About Panaxia Israel

Panaxia Labs Israel, Ltd. is a publicly-traded company at TASE (TASE: PNAX). It is the largest Israeli manufacturer and home-delivery distributor of medical cannabis products, and the first to have received the approval of the Israeli Ministry of Health for the manufacturing of medicinal cannabis-based pharmaceuticals (under the IMC-GMP directive) as well as EU-GMP standard certification required for commercial production and export of medical cannabis and its products to Europe. The company manufactures over 30 medicinal products and has accumulated a broad foundation of clinical experience based on tens of thousands of patients.

Panaxia is a subsidiary of the Segal Pharma Group, owned by the Segal family and founded over forty years ago. The company manufactures over 600 different pharmaceutical products that are distributed in over 40 countries worldwide.

Visit the Panaxia website at https://panaxia.co.il.

Infographic – https://mma.prnewswire.com/media/1485793/Panaxia_Infographic.jpg
Logo – https://mma.prnewswire.com/media/1179669/Panaxia_Logo.jpg

For more information:
[email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/panaxia-israel-announces-estimated-record-revenues-of-at-least-19-million-in-q1-2021-301266878.html

SOURCE Panaxia Pharmaceutical Industries

Posted on

RE/MAX CEO Adam Contos to Address Impact of COVID-19 on Hispanic Homeownership During NAHREP National Convention Opening General Session

RE/MAX continues commitment to growing Hispanic homeownership in collaboration with the National Association of Hispanic Real Estate Professionals

PR Newswire

DENVER, April 12, 2021 /PRNewswire/ — Tomorrow, RE/MAX Holdings CEO Adam Contos will participate in the National Association of Hispanic Real Estate Professionals (NAHREP) 2021 National Convention & Housing Policy Summit’s Opening General Session from 12:20-12:50 p.m. EDT. To register to view the session please click here and enter complimentary code NC21PRESS.

“The Latino Factor: The Key to Homeownership Growth in America” panel, moderated by 2021 NAHREP President Sara Rodriguez will address how Latinos remain the fastest growing group of homeowners in the U.S. despite receiving a disproportionately large share of the COVID-19 pandemic’s devastating financial impact. Contos will join other real estate CEOs to discuss what the industry should learn from 2020 and how the Latino factor will drive the market going forward.

“Hispanics are generally a young population and have been the only demographic to steadily increase their homeownership rate year after year,” said Contos. “They are the fastest-growing population and a driving force behind much of our economy so the opportunities for growth in the housing sector are theirs for the taking. RE/MAX agents are the best in the business at helping people achieve their homebuying and selling dreams and can expertly navigate the prevalent homeownership barriers Hispanics often face to make their dreams become a reality.”

NAHREP is a purpose-driven organization propelled by a combination of entrepreneurial spirit, cultural heritage and the advocacy of its members, whose mission is to advance sustainable Hispanic homeownership. For the past six years, RE/MAX has supported the group through education, event sponsorship, the participation of RE/MAX affiliates on NAHREP regional leadership teams and by co-sponsoring the 2020 English-Spanish Glossary of Real Estate terms with NAHREP.

“It’s so important for RE/MAX agents to connect with the entire community,” says Mike Reagan, RE/MAX Senior Vice President of Industry Relations and Global Growth & Development. “One of the wonderful things about this partnership is that our brokers embrace all the demographics in their community and tune into what is taking place in their particular market.”

Click here for more about the strategic alliance, or to learn more about NAHREP, please visit https://nahrep.org/.

About the RE/MAX Network

As one of the leading global real estate franchisors, RE/MAX, LLC is a subsidiary of RE/MAX Holdings (NYSE: RMAX) with over 135,000 agents in more than 110 countries and territories. Nobody in the world sells more real estate than RE/MAX, as measured by residential transaction sides. RE/MAX was founded in 1973 by Dave and Gail Liniger, with an innovative, entrepreneurial culture affording its agents and franchisees the flexibility to operate their businesses with great independence. RE/MAX agents have lived, worked and served in their local communities for decades, raising millions of dollars every year for Children’s Miracle Network Hospitals® and other charities. To learn more about RE/MAX, to search home listings or find an agent in your community, please visit www.remax.com. For the latest news about RE/MAX, please visit news.remax.com.

About the National Association of Hispanic Real Estate Professionals
The National Association of Hispanic Real Estate Professionals®, a nonprofit 501(c)6 trade association, is dedicated to advancing sustainable homeownership for the Hispanic community in America. NAHREP has a network of over 40,000 real estate professionals and 100 local chapters nationwide.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/remax-ceo-adam-contos-to-address-impact-of-covid-19-on-hispanic-homeownership-during-nahrep-national-convention-opening-general-session-301266844.html

SOURCE RE/MAX, LLC

Posted on

Liberty All-Star® Equity Fund Declares Distribution

PR Newswire

BOSTON, April 12, 2021  /PRNewswire/ — The Board of Trustees of Liberty All-Star Equity Fund (NYSE: USA) has declared a distribution of $0.20 per share payable on June 7, 2021 to shareholders of record on April 23, 2021 (ex-dividend date of April 22, 2021).  This distribution is in accordance with the Fund’s current distribution policy of paying distributions on its shares totaling approximately 10 percent of its net asset value per year, payable in four quarterly installments of 2.5 percent.  A portion of the distribution may be treated as paid from sources other than net income, including but not limited to short-term capital gain, long-term capital gain and return of capital.  The final determination of the source of all distributions in 2021 for tax reporting purposes, including the percentage of qualified dividend income, will be made after year-end.

The distribution will be paid in newly issued shares to all shareholders except those who are not participating in Liberty All-Star Equity Fund’s Dividend Reinvestment Plan and who elect to receive the distribution in cash.  Shares will be issued at the lower of the May 21, 2021 net asset value per share or market value per share (but not less than 95% of market value).  The market value of the Fund’s shares for this purpose will be the last sales price on the New York Stock Exchange.

The Fund does not continuously issue shares and trades in the secondary market, investors wishing to buy or sell shares need to place orders through an intermediary or broker.  The share price of a closed-end fund is based on the market’s value. The Fund’s shares are listed on the New York Stock Exchange under the ticker symbol USA. ALPS Advisors, Inc. is the investment advisor of the Fund, a multi-managed, closed-end investment company with more than $1.7 billion in net assets as of April 9, 2021.

Past performance cannot predict future results.

An investment in the Fund involves risk, including loss of principal.

ALPS Portfolio Solutions Distributor, Inc. – FINRA Member Firm

For Information Contact:
Liberty All-Star® Equity Fund
1-800-241-1850
www.all-starfunds.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/liberty-all-star-equity-fund-declares-distribution-301266854.html

SOURCE Liberty All-Star Equity Fund

Posted on

Liberty All-Star® Growth Fund, Inc. Declares Distribution

PR Newswire

BOSTON, April 12, 2021 /PRNewswire/ — The Board of Directors of Liberty All-Star Growth Fund, Inc. (NYSE: ASG) has declared a distribution of $0.17 per share payable on June 7, 2021 to shareholders of record on April 23, 2021 (ex-dividend date of April 22, 2021).  This distribution is in accordance with the Fund’s current distribution policy of paying distributions on its shares totaling approximately 8 percent of its net asset value per year, payable in four quarterly installments of 2 percent.  A portion of the distribution may be treated as paid from sources other than net income, including but not limited to short-term capital gain, long-term capital gain and return of capital.  The final determination of the source of all distributions in 2021 for tax reporting purposes, including the percentage of qualified dividend income, will be made after year-end.

The distribution will be paid in newly issued shares to all shareholders except those who are not participating in Liberty All-Star Growth Fund’s Dividend Reinvestment Plan and who elect to receive the distribution in cash.  Shares will be issued at the lower of the May 21, 2021 net asset value per share or market value per share (but not less than 95% of market value).  The market value of the Fund’s shares for this purpose will be the last sales price on the New York Stock Exchange.

The Fund does not continuously issue shares and trades in the secondary market, investors wishing to buy or sell shares need to place orders through an intermediary or broker.  The share price of a closed-end fund is based on the market’s value. The Fund’s shares are listed on the New York Stock Exchange under the ticker symbol ASG. ALPS Advisors, Inc. is the investment advisor of the Fund, a multi-managed, closed-end investment company with more than $357 million in net assets as of April 9, 2021.

Past performance cannot predict future results.

An investment in the Fund involves risk, including loss of principal.

ALPS Portfolio Solutions Distributor, Inc. – FINRA Member Firm

For Information Contact:
Liberty All-Star® Growth Fund, Inc.
1-800-241-1850
www.all-starfunds.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/liberty-all-star-growth-fund-inc-declares-distribution-301266848.html

SOURCE Liberty All-Star Growth Fund, Inc.

Posted on

Blackstone’s major milestone in 3D-printing solid-state batteries

Blackstone’s major milestone in 3D-printing solid-state batteries

BAAR, Switzerland–(BUSINESS WIRE)–
Blackstone Resources AG (SWX: BLS) is pleased to announce that is has passed a series of important milestones for its proprietary 3D-printing production technology. These milestones are focused on printing solid-state batteries, representing a significant breakthrough for this next generation technology.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210412005715/en/

Image: 5x5 cm-squared pouch cell with luminous LED (Photo: Business Wire)

Image: 5×5 cm-squared pouch cell with luminous LED
(Photo: Business Wire)

The company can now proudly announce that its German subsidiary Blackstone Technology GmbH has successfully printed and tested its first working solid-state battery cell. The picture below shows an LED light that is being powered by Blackstone’s solid-state cell.

This marks the successful completion for research and evaluating stage of the 3D screen-printing process, as a new flexible method for producing all kinds of printed solid-state lithium-ion batteries.

The following three important proof-of-concepts were achieved:

  • The completion of a 3D-printed and mechanically stable solid-state electrolyte as a separator.
  • The production of a printable composite cathode (plus the composite of a solid-state electrolyte and lithium iron phosphate)
  • The complete printing process for a 5×5 cm-squared pouch cell as a functioning demonstrator without a mechanical spacer.

Blackstone Technology’s 3D-printing and solid-state battery technologies offer substantial advantages over conventional battery cell designs which use liquid electrolytes. It allows significantly lower costs during production, increases the energy density of the cells and offers a higher number of charging cycles.

With this step, Blackstone Technology has achieved the highest efficiency and the greatest leverage from its production technology. It represents a gamechanger for the world’s entire cell manufacturing process. It also paves the way for the mass production of solid-state batteries using various cathode materials.

The automotive industry, marine applications and all other applications that require batteries stand to benefit significantly from the advantages that 3D-printed solid-state cells can offer. Our 3D printed solid-state batteries are more environment friendly as they are produced in water solvable chemicals, which are also less harmful to the environment and easier to recycle.

Blackstone Technology’s is committed to taking the next steps to develop the manufacturing technology needed to bring production to a point where one battery cell is produced every second, with production costs falling to lower than USD 65 per kWh.

Moreover, the production process offers the potential to save up to 70% of the traditional Capex and 30% Opex during the production of these solid-state cells. An additional material saving can be achieved for the electrode chemistry and other used materials.

Blackstone now has the technology and results that will be a game changer for the entire battery industry.

The company has been investing in the next generation of battery technology through its German subsidiary Blackstone Technology GmbH for many years. This includes patented 3D-printing techniques, solid-state technology and the implementation of mass production of batteries in the 3D printing processes.

The first large battery cells developed by Blackstone Technology GmbH have already been presented in February 2021 at the Blackstone Battery day and are ready for the mass production.

Blackstone Resources AG

Blackstone Resources AG is a Swiss Holding Company, with its legal domicile in Baar, Kanton Zug, and is concentrating on the battery technology and battery metals market. In addition, it sets up, develops and manages refineries used for gold and battery metals. It offers direct exposure to the battery technology and battery metals revolution that is being driven by the demand of electric vehicles that need vast quantities of these metals. These include cobalt, manganese, graphite, nickel, copper and lithium. In addition, Blackstone Resources has started a research program on new battery technologies on solid state batteries and its production process.

For more information please visit www.blackstoneresources.ch.

The disclaimer is an integral part of this press release. Please ensure you consult the disclaimer for a full understanding of the content within:

http://www.blackstoneresources.ch/investors/disclaimer/

Blackstone Resources AG

Ms. Doris Suta

T: +41 41 449 61 63

F: +41 41 449 61 69

[email protected]

Blegistrasse 5

CH-6340 Baar

Switzerland

Investor Relations

[email protected]

Media Enquiries

[email protected]

KEYWORDS: Switzerland United Kingdom Canada North America Europe Germany

INDUSTRY KEYWORDS: Other Energy Software Other Communications Energy Data Management Communications Technology Mobile/Wireless

MEDIA:

Photo
Photo
Image: 5×5 cm-squared pouch cell with luminous LED
(Photo: Business Wire)
Posted on

Nanobiotix Combined Shareholders Meeting to Be Held April 28, 2021

Nanobiotix Combined Shareholders Meeting to Be Held April 28, 2021

Availability of Preparatory Documents and Methods for Voting Participation

PARIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)–
Regulatory News:

NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the ‘‘Company’’) (Paris:NANO) (NASDAQ:NBTX), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that its annual Combined Shareholders Meeting is to be held on April 28, 2021 at 5pm Central European Time (CET), 11am Eastern Standard Time (EST), by way of web conference.

Given the health measures related to COVID-19, the meeting will be held behind closed doors without the physical presence of shareholders. The meeting can be attended by logging into https://channel.royalcast.com/landingpage/nanobiotix/20210428_1/.

Availability of Preparatory Documents

All preparatory documents related to the meeting, including postal voting forms and proxy forms, are available upon request via email at [email protected] or via the Company’s website at https://www.nanobiotix.com/annual-general-meetings/.

Methods for Voting and Submission of Written Questions

Due to its closed-door configuration of the meeting, voting at the meeting will not be possible. As such, Nanobiotix invites shareholders to express their vote to the meeting chairman via postal voting or by proxy. The voting methods are detailed in the convene notice published in the Bulletin des Annonces Légales Obligatoires – BALO on April 12, 2021.

The meeting configuration will also prevent Nanobiotix from receiving live questions during the meeting. As such, written questions must be sent to [email protected]at least four (4) business days prior to the meeting (i.e., April 22, 2021). The questions must be accompanied by the admission card or the shareholder’s certificate of participation either in the registered securities accounts or in the bearer securities accounts held by the intermediary.

The organization of the Combined Shareholders Meeting is subject to change depending on health measures and/or legal requirements. Shareholders are therefore invited to regularly consult https://www.nanobiotix.com/annual-general-meetings/ to remain up to date with the latest announcements from the Company.

About NANOBIOTIX: www.nanobiotix.com

Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity. The company’s philosophy is rooted in the concept of pushing past the boundaries of what is known to expand possibilities for human life.

Incorporated in 2003, Nanobiotix is headquartered in Paris and also has subsidiaries in France, Spain, and Germany. Nanobiotix has been listed on Euronext: Paris since 2012 and completed a successful initial public offering (IPO) on the Nasdaq Global Select Market in New York City in December 2020. The company is one of only 7 dual-listed biotech companies with headquarters in France.

Nanobiotix is the owner of more than 30 umbrella patents associated with three (3) nanomedicine platforms: 1) applied to oncology; 2) applied to bioavailability and biodistribution; and 3) applied to disorders of the central nervous system. The lion’s share of the company’s resources are devoted to the development of its lead product candidate–NBTXR3—which was born from its proprietary oncology platform and is has already achieved market authorization in Europe for the treatment of patients with soft tissue sarcoma under the brand name Hensify®.

For more information about Nanobiotix, visit us at www.nanobiotix.com or follow us on LinkedIn and Twitter

Disclaimer

This press release contains certain “forward-looking” statements within the meaning of applicable securities laws, including the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words such as “at this time,” “anticipate,” “believe,” “expect,” “intend,” “on track,” “plan,” “scheduled,” and “will,” or the negative of these and similar expressions. These forward-looking statements, which are based on our management’s current expectations and assumptions and on information currently available to management, include statements about the timing and progress of clinical trials, the timing of our presentation of data, the results of our preclinical studies and their potential implications. Such forward-looking statements are made in light of information currently available to us and based on assumptions that Nanobiotix considers to be reasonable. However, these forward-looking statements are subject to numerous risks and uncertainties, including with respect to the risk associated with the evolving nature of the duration and severity of the COVID-19 pandemic and governmental and regulatory measures implemented in response to it. Furthermore, many other important factors, including those described in our Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission on April 7, 2021 under “Item 3.D. Risk Factors” and those set forth in the universal registration document of Nanobiotix filed with the French Financial Markets Authority (Autorité des Marchés Financiers) under number D.21-0272 on April 7, 2021 (a copy of which is available on www.nanobiotix.com), as well as other known and unknown risks and uncertainties may adversely affect such forward-looking statements and cause our actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons why actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future.

Nanobiotix

Communications Department

Brandon Owens

VP, Communications

+1 (617) 852-4835

[email protected]

Investor Relations Department

Kate McNeil

SVP, Investor Relations

+1 (609) 678-7388

[email protected]

Media Relations

France – Ulysse Communication

Pierre-Louis Germain

+ 33 (0) 6 64 79 97 51

[email protected]

US – Porter Novelli

Stefanie Tuck

+1 (917) 390-1394

[email protected]

KEYWORDS: Europe United States North America France Massachusetts

INDUSTRY KEYWORDS: Oncology Professional Services Health Medical Devices Other Health Finance Biotechnology

MEDIA:

Logo
Logo
Posted on

Asana Named #1 Best Workplace in Technology™ by Great Place to Work® and FORTUNE

Asana Named #1 Best Workplace in Technology™ by Great Place to Work® and FORTUNE

SAN FRANCISCO–(BUSINESS WIRE)–
For the second year in a row, Great Place to Work and FORTUNE have named Asana, Inc. (NYSE: ASAN), a leading work management platform for teams, the number one Best Workplace in Technology™. Marking the fourth year for Asana in the list’s top three ranking, 98% of Asana’s employees said Asana is a great place to work, 39% higher than the average U.S. company.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210412005177/en/

Marking the fourth year for Asana in the list’s top three ranking, 98% of Asana’s employees said Asana is a great place to work, 39% higher than the average U.S. company. (Graphic: Business Wire)

Marking the fourth year for Asana in the list’s top three ranking, 98% of Asana’s employees said Asana is a great place to work, 39% higher than the average U.S. company. (Graphic: Business Wire)

The recognition marks the sixth outstanding honor for Asana in 2021. Asana was recently named #14 on Employees’ Choice Award and #1 on G2’s Grid Report for Project Management list. Earlier this year, Great Place to Work and Fortune awarded Asana the #1 Best Small and Medium Workplace in the Bay Area and #14 Best Small Workplace in Ireland. Last month, Asana was named #15 on Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2021, including a #1 ranking in the Workplace category.

“At Asana, our mission is to help our customers achieve their missions faster,” said Alex Hood, Chief Product Officer, Asana. “Accomplishing great things takes great teamwork, and we’re honored to be recognized as the Best Workplace in Technology. It’s a testament to the culture of trust, empathy and innovation we’ve co-created with our employees as we pioneer a new way to work.”

Great Place to Work, the global authority on workplace culture, selected this year’s Best Workplaces in Technology list using rigorous analytics and confidential employee feedback. Companies are assessed on how well they are creating a great employee experience that cuts across race, gender, age, disability status or any aspect of who employees are or what their role is.

“It’s more than fancy perks at the Best Workplaces in Technology. Employees at the companies praised their leaders for their incredible transparency and care during this pandemic year,” said Sarah Lewis-Kulin, VP global recognition, Great Place to Work®. “Even while working from home, employees said they felt more connected to their colleagues and their communities than ever.”

The full 2021 lists of organizations and award winners, as well as rankings from previous years, are available at www.greatplacetowork.com/best-workplaces/.

About Asana

Asana helps teams orchestrate their work, from small projects to strategic initiatives. Headquartered in San Francisco, CA, Asana has more than 93,000 paying organizations and millions of free organizations across 190 countries. Global customers such as Accenture, Estee Lauder, Japan Airlines, Sky and Viessmann rely on Asana to manage everything from company objectives to digital transformation to product launches and marketing campaigns. For more information, visit www.asana.com.

About the Best Workplaces in Technology™

Great Place to Work® selected the Best Workplaces in Technology™ by gathering and analyzing confidential survey responses from more than 122,000 employees at Great Place to Work-Certified™ organizations across the country. Company rankings are derived from 60 employee experience questions within the Great Place to Work Trust Index™ survey. Read the full methodology.

About Great Place to Work®

Great Place to Work® is the global authority on workplace culture. Since 1992, they have surveyed more than 100 million employees worldwide and used those deep insights to define what makes a great workplace: trust. Their employee survey platform empowers leaders with the feedback, real-time reporting and insights they need to make data-driven people decisions. Everything they do is driven by the mission to build a better world by helping every organization become a great place to work For All™.

Leah Wiedenmann

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Data Management Security Technology Software Networks Internet

MEDIA:

Logo
Logo
Photo
Photo
Marking the fourth year for Asana in the list’s top three ranking, 98% of Asana’s employees said Asana is a great place to work, 39% higher than the average U.S. company. (Graphic: Business Wire)
Posted on

Carlisle Companies Publishes 2020 Sustainability Report and Launches New Website Focused on ESG

Carlisle Companies Publishes 2020 Sustainability Report and Launches New Website Focused on ESG

SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Carlisle Companies Incorporated (NYSE:CSL) today published its 2020 Sustainability Report in conjunction with a new ESG-focused website (www.carlisle.com/sustainability). The 2020 report and new website share details of Carlisle’s century-long journey and provide a deeper look into Carlisle’s socially and fiscally responsible approach to create value for its stakeholders, including customers, employees, suppliers, shareholders and the communities in which we operate.

David W. Smith, Vice President, Sustainability, said, “The publication of our 2020 Sustainability Report and our new ESG web portal are important steps in giving our stakeholders increased access to Carlisle’s progress and data related to product-specific efficiency attributes, safety, training, Diversity and Inclusion as well as topic-specific GRI data. As we deliver on Vision 2025, Carlisle remains steadfast in our commitment to ESG and another century of responsible stewardship.”

About Carlisle Companies Incorporated

Carlisle Companies Incorporated is a diversified industrial company with a global portfolio of niche brands that delivers energy efficient and highly engineered products and solutions for its customers. Driven by our strategic plan, Vision 2025, Carlisle is committed to generating superior shareholder returns by investing in high-ROIC businesses and maintaining a balanced capital deployment approach, including investments in our businesses, strategic acquisitions, share repurchases and continued dividend increases. Carlisle is headquartered in Scottsdale, Arizona. Its worldwide team of employees generated $4.2 billion in revenues in 2020.

Jim Giannakouros, CFA

Vice President of Investor Relations

Carlisle Companies Incorporated

(480) 781-5135

[email protected]

KEYWORDS: Arizona United States North America

INDUSTRY KEYWORDS: Engineering Chemicals/Plastics Automotive Manufacturing Environment Aerospace Manufacturing Steel

MEDIA:

Logo
Logo
Posted on

AGEAS Continues Technology Collaboration with CoreLogic to Deliver on Their Long-Term Digitalization Strategy

AGEAS Continues Technology Collaboration with CoreLogic to Deliver on Their Long-Term Digitalization Strategy

CoreLogic’s claims solution to provide seamless workflows for AGEAS’s claims handlers while accelerating claims resolutions

IRVINE, Calif.–(BUSINESS WIRE)–
CoreLogic® (NYSE: CLGX), a leading global property information, analytics and data-enabled solutions provider, today announced that AGEAS, one of the largest insurance carriers in the United Kingdom, has decided to strengthen their strategic technology collaboration with CoreLogic with a new multi-year-agreement. AGEAS is using CoreLogic’s claims platform to positively influence claims outcomes through a secure, real-time, cloud-based web application that can be accessed anywhere and from any device.

“AGEAS’s goal is to simplify insurance for our customers through a personal, tailored and seamless claims experience,” said Rob Hopkins, Head of Home, Commercial and Travel Claims Operations at AGEAS UK, “We have decided to renew our relationship with CoreLogic because we trust in their technology and in their team’s ability to help us achieve this goal.”

CoreLogic’s platform enables AGEAS’s claims handlers to provide customer choice, and faster resolution within their high-volume claims processes. Using CoreLogic’s functionality, AGEAS handlers can provide remote claims assessment, including the ability for the customer to choose their preferred settlement route—with the option for immediate settlement from first notice of loss.

“We are very happy that AGEAS UK has continued to place their trust in our platform,” said Michael Porter, Senior Leader of International Markets at CoreLogic. “We are looking forward to working with AGEAS in the coming years to add incremental value to their business and customers through this relationship.”

CoreLogic offers digital insurance solutions with modernized communication tools and seamless claims workflow and management systems. CoreLogic helps standardize claims processing on a single, cloud-based platform to increase productivity gains and enable improved transparency into the claims management process.

“Since using CoreLogic’s platform we have been able to speed up the customer journey, especially on lower complexity claims. This saves time and reduces the disruption felt by our customers in what are often difficult circumstances,” said Hopkins. “The efficiency we have gained means we are able to focus our resources on the customers who need more direct engagement and support in their time of need.”

About CoreLogic

CoreLogic (NYSE: CLGX), the leading provider of property insights and solutions, promotes a healthy housing market and thriving communities. Through its enhanced property data solutions, services and technologies, CoreLogic enables real estate professionals, financial institutions, insurance carriers, government agencies and other housing market participants to help millions of people find, buy and protect their homes. For more information, please visit www.corelogic.com.

CORELOGIC, and the CoreLogic logo are trademarks of CoreLogic, Inc. and/or its subsidiaries. All other trademarks are the property of their respective owners.

About AGEAS

AGEAS is one of the largest general insurers in the United Kingdom, providing insurance to over five million customers. It offers car, home, pet, and small business insurance through brokers, affinity partners and its own brands.

AGEAS is a wholly owned subsidiary of AGEAS Group, which is listed on the Belgium stock exchange. AGEAS (UK) Limited registered office: AGEAS House, Hampshire Corporate Park, Templars Way, Eastleigh, Hampshire, SO53 3YA. Registered number: 1093301. Registered in England and Wales. www.ageas.co.uk

AGEAS Insurance Limited is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority, Financial Services Register No. 202039.

Amy Brennan

Corporate Communications

[email protected]

AGEAS

[email protected]

KEYWORDS: Europe United States United Kingdom North America California

INDUSTRY KEYWORDS: Technology Insurance Construction & Property Security Other Technology REIT Professional Services Internet Data Management

MEDIA:

Posted on

Transgene Announces Upcoming Investor Meetings

Transgene Announces Upcoming Investor Meetings

STRASBOURG, France–(BUSINESS WIRE)–
Regulatory News:

Strasbourg, France, April 12, 2021, 05:45 pm CET – Transgene (Paris:TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, today announces that Management will participate in the upcoming investor events set out below:

– SmallCap Event – Digital event

14 & 15 April 2021

– KEMPEN LIFE SCIENCES CONFERENCE – 2021 Thematic Virtual Series

21 April2021 – Immuno and Targeted Oncology

– Spring European Midcap Event– Digital event

22 & 23 June 2021

***

About Transgene

Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer. Transgene’s programs utilize viral vector technology with the goal of indirectly or directly killing cancer cells. The Company’s clinical-stage programs consist of two therapeutic vaccines (TG4001 for the treatment of HPV-positive cancers, and TG4050, the first individualized therapeutic vaccine based on the myvac® platform) as well as two oncolytic viruses (TG6002 for the treatment of solid tumors, and BT-001, the first oncolytic virus based on the Invir.IO™ platform).

With Transgene’s myvac® platform, therapeutic vaccination enters the field of precision medicine with a novel immunotherapy that is fully tailored to each individual. The myvac® approach allows the generation of a virus-based immunotherapy that encodes patient-specific mutations identified and selected by Artificial Intelligence capabilities provided by its partner NEC.

With its proprietary platform Invir.IO™, Transgene is building on its viral vector engineering expertise to design a new generation of multifunctional oncolytic viruses. Transgene has an ongoing Invir.IO™ collaboration with AstraZeneca.

Additional information about Transgene is available at: Follow us on Twitter: @TransgeneSA

Disclaimer

This press release contains forward-looking statements, which are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated. The occurrence of any of these risks could have a significant negative outcome for the Company’s activities, perspectives, financial situation, results, regulatory authorities’ agreement with development phases, and development. The Company’s ability to commercialize its products depends on but is not limited to the following factors: positive pre-clinical data may not be predictive of human clinical results, the success of clinical studies, the ability to obtain financing and/or partnerships for product manufacturing, development and commercialization, and marketing approval by government regulatory authorities. For a discussion of risks and uncertainties which could cause the Company’s actual results, financial condition, performance or achievements to differ from those contained in the forward-looking statements, please refer to the Risk Factors (“Facteurs de Risque”) section of the Universal Registration Document, available on the AMF website (http://www.amf-france.org) or on Transgene’s website (www.transgene.fr). Forward-looking statements speak only as of the date on which they are made and Transgene undertakes no obligation to update these forward-looking statements, even if new information becomes available in the future.

Transgene:

Lucie Larguier

Director Corporate Communications & IR

+33 (0)3 88 27 91 04

[email protected]

Media: Citigate Dewe Rogerson

David Dible/Sylvie Berrebi

+ 44 (0)20 7638 9571

[email protected]

KEYWORDS: France Europe

INDUSTRY KEYWORDS: Oncology Health Hospitals Other Health Clinical Trials Pharmaceutical Biotechnology

MEDIA: